|Bid||6.32 x 800|
|Ask||7.60 x 1000|
|Day's Range||6.32 - 6.32|
|52 Week Range||4.01 - 10.15|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 23, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Adjusted EBITDA up 58% to $8.8 million in 4Q19 and 85% to $41.3 million in FY19 HB4® Drought Tolerant Soybean technology approved by the USDA
Bioceres Crop Solutions Corp. , a fully integrated provider of crop productivity solutions, today announced Financial Officer Enrique Lopez Lecube will be presenting at this year’s Fall Investor Summit taking place on September 16th and 17th at The Essex House in New York City.
ROSARIO, Argentina-- -- Bioceres Crop Solutions Corp. , a fully integrated provider of crop productivity solutions, today announced that it plans to report its Fourth Quarter and Fiscal Year 2019 results on Friday, September 13, 2019 after the close of the New York Stock Exchange. The Company will host a conference call on Monday, September 16, 2019 at 8:30 a.m. ET to discuss fourth-quarter results, ...
Shares of Arcadia Biosciences Inc. rocketed 97.5% on very heavy volume Friday, after Verdeca, a joint venture between Arcadia and Bioceres Crop Solutions Corp. , said it received approval from the U.S. Department of Agriculture to commercialize its HB4 drought-tolerant soybeans. Trading volume in Arcadia's stock was 28.5 million shares, compared with the full-day average of about 127,000 shares. The rally comes after the stock closed at a record low of $1.92 on Monday Aug. 5. Bioceres's stock rose 6% in morning trading. "HB4 is a novel soybean trait that enhances the traditional herbicide tolerance package to provide yield stability across diverse environments," said Verdeca General Manager Martin Mariani Ventura. "Approval of this technology in the United States is a significant step for the successful commercialization of HB4 technology in the global soybean market." Arcadia's stock has still lost 22.7% over the past three months, while Bioceres shares have run 54.5% and the S&P 500 has gained 1.3%.
-- Novel trait stack expected to help growers facing climate and production challenges -- -- HB4 trait now has regulatory approval in more than 80 percent of the global soybean market -- DAVIS, Calif. ...
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Adjusted EBITDA for the nine-month period ended March 31, 2019 increased by 94%. Management expects to exceed guidance of $38 million for fiscal year ending June 30, 2019.
Please replace the first paragraph of the release with the following corrected version due to multiple revisions.